Condition: Arthroscopic Meniscectomy
Purpose: To evaluate the safety and efficacy of OMS103HP-S administered in joint irrigation solution to subjects undergoing arthroscopic meniscectomy
Principal Investigator: Christopher Cannon, MD
Study Coordinator: Jill Elwell
Phone: (206) 860-4761
E-mail: research@polyclinic.com
Condition: Clostridium difficile Infection
Purpose: To evaluate the efficacy, safety, and tolerability of a single infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to Clostridium difficile toxin B), and MK-3415A (Human Monoclonal Antibodies to Clostridium difficile toxin A and toxin B) in patients receiving antibiotic therapy for clostridium difficile infection
Principal Investigator: Warren Dinges, MD
Study Coordinator: Brenda Balogh, RN
Phone: (206) 320-6752
E-mail: research@polyclinic.com
Condition: Gout
Purpose: To evaluate the efficacy and safety of lesinurad monotherapy compared to placebo in subjects with gout and an intolerance or contraindication to a xanthine oxidase inhibitor (LIGHT)
Principal Investigator: Elton Lee, MD
Study Coordinator: Michelle Harder, MA
Phone: (206) 860-5432
E-mail: research@polyclinic.com
Condition: Gout
Purpose: To evaluate the efficacy and safety of lesinurad and allopurinol compared to allopurinol alone in subjects with gout who have had an inadequate hypouricemic response to standard of care allopurinol (CLEAR)
Principal Investigator: Elton Lee, MD
Study Coordinator: Michelle Harder, MA
Phone: (206) 860-5432
E-mail: research@polyclinic.com
Condition: Hepatitis C/HIV-1
Purpose: To evaluate telaprevir in combination with peginterferon alfa-2a (Pegasys®) and ribavirin (Copegus®) in subjects co-infected with genotype 1 hepatitis C virus and human immunodeficiency virus type 1(HCV/HIV-1)
Principal Investigator: Warren Dinges, MD
Study Coordinator: Michelle Harder, MA
Phone: (206) 860-5432
E-mail: research@polyclinic.com
Condition: Hypercholesterolemia
Purpose: To evaluate long-term tolerability and durable efficacy of AMG 145 on LDL-C in hypercholesterolemia subjects
Principal Investigator: Kier Huehnergarth, MD
Study Coordinator: Marilou Schrenker, MA
Phone: (206) 320-6692
E-mail: research@polyclinic.com
Condition: Lupus
Purpose: To evaluate the efficacy and safety of subcutaneous LY2127399 in patients with systemic lupus erythematosus (SLE)
Principal Investigator: Anthony Krajcer, MD
Study Coordinator: Brenda Balogh, RN
Phone: (206) 320-6752
E-mail: research@polyclinic.com
Condition: Migraine Headache
Purpose: To evaluate the efficacy of zolmitripatan 0.5-, 2.5- and 5-mg nasal spray in the treatment of acute migraine headache in adolescents
Principal Investigator: Lauren Plawner, MD
Study Coordinator: Brenda Balogh, RN
Phone: (206) 320-6752
E-mail: research@polyclinic.com
Condition: Neuropathic Pain
Purpose: To evaluate the efficacy and safety of SAR292833 administration for 4 weeks in patients with chronic peripheral neuropathic pain
Principal Investigator: Benduan Yang, MD
Study Coordinator: Marilou Schrenker, MA
Phone: (206) 320-6692
E-mail: research@polyclinic.com
Condition: Nocturia
Purpose: To evaluate the efficacy and safety of SER120 nasal spray formulation in patients with nocturia
Principal Investigator: Emily Bradley, MD
Study Coordinator: Jill Elwell
Phone: (206) 860-4761
E-mail: research@polyclinic.com
Condition: Polycystic Kidney Disease
Purpose: To evaluate the safety, clinical activity, and pharmacokinetics of bosutinib versus placebo in subjects with autosomal dominant polycystic kidney disease (ADPKD)
Principal Investigator: Bruce O’Neill, MD
Study Coordinator: Kenita Davis, MA
Phone: (206) 320-6766
E-mail: research@polyclinic.com
Condition: Rosacea
Purpose: To evaluate the efficacy and safety of CD5024 1% cream versus placebo cream in subjects with papulopustular rosacea, followed by a 40-week extension comparing the long-term safety of CD5024 1% cream versus azelaic acid 15% gel
Principal Investigator: Kim Abson, MD
Study Coordinator: Jill Elwell
Phone: (206) 860-4761
E-mail: research@polyclinic.com
Condition: Vascular Disease
Purpose: To evaluate the clinical effects of anacetrapid among people with established vascular disease
Principal Investigator: Kier Huehnergarth, MD
Study Coordinator: Marilou Schrenker, MA
Phone: (206) 320-6692
E-mail: research@polyclinic.com